# Evaluation of Initiation Time on the Efficacy of Gabapentin in Treating Neuropathic Pain in SCI

> **NCT04256603** · PHASE4 · COMPLETED · sponsor: **MetroHealth Medical Center** · enrollment: 27 (actual)

## Conditions studied

- Spinal Cord Injuries
- Neuropathic Pain

## Interventions

- **DRUG:** Gabapentin
- **OTHER:** No gabapentin

## Key facts

- **NCT ID:** NCT04256603
- **Lead sponsor:** MetroHealth Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-08-01
- **Primary completion:** 2020-03-30
- **Final completion:** 2020-04-01
- **Target enrollment:** 27 (ACTUAL)
- **Last updated:** 2021-11-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04256603

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04256603, "Evaluation of Initiation Time on the Efficacy of Gabapentin in Treating Neuropathic Pain in SCI". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04256603. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*